REDWOOD CITY, Calif., September 10, 2026
Healthcare AI Gets First Standardized Research Framework as Suki Launches Industry Initiative
REDWOOD CITY, Calif. – Suki, the leading Ambient Clinical Intelligence platform, announced Thursday the launch of Science at Suki, an industry-wide research initiative designed to establish standardized evaluation frameworks for healthcare AI implementation across clinical settings.
The initiative launches with the Suki Research Collaborative, a research network uniting major health systems including the Regenstrief Institute, the National Center for Human Factors in Healthcare at MedStar Health, University of Miami Miller School of Medicine, and Rush University System for Health.
The timing comes as healthcare organizations rapidly deploy AI tools without consistent metrics to measure their clinical and financial impact. A recent study from the Consortium for Health AI and the University of Chicago's National Opinion Research Center found that while 75 percent of healthcare respondents reported using AI tools, only 13 percent expressed strong confidence in the technology. More than half indicated AI had reduced their trust in healthcare systems, with 93 percent reporting at least one concern about AI deployment.
"The future of Ambient Clinical Intelligence won't be defined solely by technological breakthroughs. It will be defined by the quality of the evidence behind them," said Sudha Jayaraman, MD, MSc, FACS, Medical Director of Clinical Strategy and Research at Suki and Chair of the Suki Research Collaborative.
Jayaraman, who joined Suki from the University of Utah where she held a full professorship and endowed chair focused on health innovation, brings more than 110 peer-reviewed publications to the initiative. The Suki Research Collaborative will examine AI implementation patterns, human factors affecting clinician adoption, workflow optimization strategies, and the development of standardized frameworks for measuring clinical, operational, and economic outcomes.
Initial research efforts will focus on developing a gold-standard evaluation framework with the Regenstrief Institute. This framework will provide health systems with evidence-based methodologies to assess ambient AI performance, moving beyond anecdotal success stories toward consistent, peer-reviewed evaluation standards.
The initiative builds on Suki's existing research portfolio already published in major medical journals. A June 2026 study in JMIR Medical Informatics found that Suki implementation reduced documentation time by 35 percent and generated projected revenue gains of $2,629 per provider monthly. Another peer-reviewed study published in June 2026 established a conceptual model for ambient AI adoption, providing health systems with decision-making frameworks for technology implementation.
A third study published in August 2026 outlined guardrails for medical education applications, addressing how AI can support clinical training while maintaining learning integrity. These studies provide the foundation for expanded research through the Suki Research Collaborative.
Additional research pipelines will examine performance metrics across diverse specialties, safety considerations for autonomous AI agents, and the impact of AI deployment on clinical reasoning skills. Findings will be published in peer-reviewed open-access journals to ensure transparency and accountability across healthcare organizations.
"The evidence base needs to catch up with deployment speed," said Jayaraman. "By bringing together leading clinicians, researchers, engineers, and health systems to generate objective evidence, we're helping healthcare organizations adopt Ambient Clinical Intelligence with the confidence needed to improve patient care, support clinicians, and advance the practice of medicine."
The Suki Research Collaborative represents a shift toward evidence-based healthcare AI adoption. As health systems move beyond asking whether AI works to understanding how well it performs, when it should be deployed, and what outcomes it delivers, standardized evaluation becomes essential for responsible implementation.
Industry observers note that standardized research frameworks could accelerate adoption while maintaining safety standards. Health systems face growing pressure to integrate AI into clinical workflows while managing concerns about accuracy, bias, and clinician trust.
Suki's research pipeline includes ongoing studies on performance measurements, safety in agentic AI, and adoption patterns. Results will support health systems making informed technology decisions while maintaining focus on patient outcomes and clinician experience.
As healthcare organizations navigate increasing AI adoption, the availability of standardized research frameworks may determine whether technology investment delivers promised benefits. The Suki Research Collaborative aims to provide that foundation through peer-reviewed evidence and transparent methodologies.
Sources:
Mira West
Senior Research Communications Fellow · Foresight Institute of Research and Translation
Senior Research Communications Fellow specializing in research translation, higher education infrastructure, and technical innovation across African universities. Leads institutional synthesis for technological development frameworks.
